WHO’s Global Report on Hypertension 2025 reveals 1.4 billion people now live with high blood pressure, the silent killer driving global health risks
Nilambar Rath
“Global report on hypertension 2025: high stakes – turning evidence into action,” underscores the urgent need for governments and public health systems worldwide to intensify efforts against a condition often dubbed the “silent killer” for its lack of early symptoms.
A staggering 1.4 billion adults worldwide are now living with hypertension, a silent condition that has doubled its global reach since 1990 and is a leading cause of premature death from heart attacks, strokes, and kidney failure.
A landmark new report from the World Health Organization (WHO) sounds the alarm on this escalating public health crisis. Titled “Global report on hypertension 2025: high stakes – turning evidence into action,” the report serves as an urgent call for political and public health leaders, particularly in high-burden regions like South and Southeast Asia, to adopt proven, cost-effective strategies to turn the tide against this preventable killer.
Here’s what you need to know from the WHO’s latest findings:
- An Alarming Rise:The number of adults aged 30-79 with hypertension has surged from 650 million in 1990 to 1.4 billion in 2024, with projections suggesting it could surpass 1.5 billion by 2030 if urgent action is not taken.
- A Deadly Gap in Care:Globally, over a billion people with hypertension do not have it under control, with only 23% of those affected being managed effectively. This gap is particularly wide in low- and middle-income countries.
- Success is Possible:The report stresses that this is a winnable battle. It highlights practical roadmaps from countries like Bangladesh and the Philippines, which have demonstrated that strong political will and the integration of hypertension care into primary health services can dramatically improve control rates.
A Silent Killer’s Staggering Toll
Hypertension, or high blood pressure, often presents no early symptoms, earning its moniker as the “silent killer”. Yet, its consequences are devastatingly loud. Uncontrolled, it is a primary driver of heart attacks, strokes, chronic kidney disease, and dementia. The WHO report underscores the sheer scale of the human cost, attributing11 million deaths in 2011 (16% of all deaths worldwide) to high blood pressure—making it a more deadly risk factor than any other for noncommunicable diseases (NCDs).
Beyond the loss of life, the economic burden is immense. For low- and middle-income countries, the report estimates that cardiovascular diseases, including hypertension, led to economic losses of US$ 3.7 trillion between 2011 and 2025.
These costs strain national health systems and push families into poverty due to out-of-pocket medical expenses and lost productivity.
The report reveals a concerning disparity in healthcare response: 99 countries have hypertension control rates below 20%, illustrating a global failure in prevention, detection, and long-term management.
A stroke patient taking robotic therapy at an Advanced Rehabilitation Center (ARC)
Turning the Tide: A Roadmap from Evidence to Action
The report’s core message is one of optimistic urgency: improving hypertension control is possible and scalable. It moves beyond just outlining the problem to providing a clear blueprint for success, drawing on real-world examples relevant to the South and Southeast Asian context.Countries like Bangladesh and the Philippines are presented as powerful case studies. By embedding hypertension services into essential primary healthcare packages and adopting the WHO HEARTS technical package, these nations have achieved remarkable improvements in treatment and control at subnational levels. Their success is attributed to a combination of strong political leadership, coherent policies that integrate hypertension care into the Universal Health Coverage (UHC) agenda, strategic funding, and deep community engagement.
This progress is built on a four-pronged strategy that any country can adapt:
- Prevention and Health Promotion:Implementing policies to reduce risk factors like high salt intake, physical inactivity, and tobacco use.
- Accurate Diagnosis:Making blood pressure measurement a routine part of every primary care visit.
- Effective Treatment:Ensuring a reliable supply of affordable medications, using simplified treatment protocols, and adopting team-based care models.
- Continuity of Care:Empowering patients with self-management and using tracking systems to ensure they remain in care.
WHO’s Five-Point Action Plan
Based on this evidence, the report concludes with five overarching recommendations for governments and public health bodies to accelerate progress against hypertension:
- Integrate hypertension interventions into UHC reforms, ensuring that prevention and care are included in national health benefit packages.
- Improve access to affordable antihypertensive medicinesand validated blood pressure measurement devices by strengthening regulatory systems and updating essential medicines lists.
- Invest in the health workforce and expand team-based care, allowing trained non-physician health workers to diagnose, treat, and monitor patients.
- Monitor trends and progress by strengthening health information systems, setting national control targets of at least 50% and transparently tracking outcomes.
- Raise public awarenessabout the dangers of hypertension and empower communities to demand and seek care, making its prevention and control everyone’s business.
The message from the WHO is unequivocal: the strategies to control hypertension are known, cost-effective, and readily available. The time to turn this evidence into life-saving action is now.
#NonCommunicableDisease #HighBloodPressure
(The author is the Co-Chair of IFI Foundation and the Founder & CEO of OdishaLIVE. A senior journalist, he has a deep interest in public health communication, media, and entrepreneurship. He leads the IFI Foundation’s stroke awareness initiative as the Campaign Chair.)
Courtesy: OdishaPlus



